Newborn Screening Implementation Program Regarding Conditions Added to the Recommended Uniform Screening Panel (RUSP)

Funding Opportunity Number: HRSA-16-062 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.110Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-HRSAClosing Date: May 27, 2016Award Ceiling: $0Expected Number of Awards: 1Creation Date: Mar 28, 2016Funding Opportunity Description: This announcement solicits applications for the Newborn Screening Implementation Program Regarding Conditions Added to the Recommended Uniform Screening Panel (RUSP).  The overall goal for this initiative is to increase the number of newborns receiving early treatment for Pompe disease, Mucopolysaccharidosis I (MPS I), and X-linked Adrenoleukodystrophy (X-ALD) by: fostering the integration of and building capacity for newborn screening for these conditions; increasing the number of NBS laboratory scientists and short-term follow-up personnel with knowledge and skill in conducting newborn screening and short-term follow-up for Pompe disease, MPS 1, and X-ALD; providing training, education, and sharing of information via a national meeting for the public health community; supporting primary health care providers through education and resources, with special attention to cases with later onset of symptoms; and engaging families in the development and dissemination of educational materials and supp...
Source: Grants.gov - Category: Research Tags: Health Source Type: funding